Evidence map›Paper›PMID 37693900›Full record

ArticleFrontiers in pharmacology2023

Standardized

Soundararajan Vijayarathna, Chern Ein Oon, Majid Al-Zahrani, Muyassar H Abualreesh, Yeng Chen, Jagat R Kanwar, Sumaira Sahreen, Shakira Ghazanfar, Mohd Adnan, Sreenivasan Sasidharan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Soundararajan VijayarathnaInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Chern Ein OonInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Majid Al-ZahraniBiological Sciences Department, College of Science and Arts, King Abdulaziz University, Rabigh, Saudi Arabia.
Muyassar H AbualreeshDepartment of Marine Biology, Faculty of Marine Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Yeng ChenDepartment of Oral and Craniofacial Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
Jagat R KanwarDepartment of Biochemistry, All India Institute of Medical Sciences (AIIMS), Bilaspur, India.
Sumaira SahreenInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Shakira GhazanfarNational Institute of Genomics and Advanced Biotechnology (NIGAB), National Agriculture Research Centre (NARC), Islamabad, Pakistan.
Mohd AdnanDepartment of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Sreenivasan SasidharanInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Universiti Sains Malaysia · MYKing Abdulaziz University · SAAll India Institute of Medical Sciences Raipur · INUniversity of Ha'il · SAUniversity of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancerapoptosisgene ontologymiRNAPolyalthia longifoliastandardized extract

Identifiers

PMID37693900
PMCPMC10483226
OpenAlexW4386141449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.